Cross Country Healthcare, Inc.

NasdaqGS:CCRN Stok Raporu

Piyasa değeri: US$383.1m

Cross Country Healthcare Yönetim

Yönetim kriter kontrolleri 3/4

Cross Country Healthcare's CEO is John Martins, appointed in Apr 2022, has a tenure of 2.58 years. total yearly compensation is $3.51M, comprised of 24.8% salary and 75.2% bonuses, including company stock and options. directly owns 0.46% of the company’s shares, worth $1.76M. The average tenure of the management team and the board of directors is 3.5 years and 5.2 years respectively.

Anahtar bilgiler

John Martins

İcra Kurulu Başkanı

US$3.5m

Toplam tazminat

CEO maaş yüzdesi24.8%
CEO görev süresi2.6yrs
CEO sahipliği0.5%
Yönetim ortalama görev süresi3.5yrs
Yönetim Kurulu ortalama görev süresi5.2yrs

Son yönetim güncellemeleri

Recent updates

Cross Country Healthcare: The Strong Balance Sheet Provides A Sufficient Margin Of Safety

Oct 15

Cross Country Healthcare, Inc.'s (NASDAQ:CCRN) Shares Bounce 30% But Its Business Still Trails The Market

Jul 31
Cross Country Healthcare, Inc.'s (NASDAQ:CCRN) Shares Bounce 30% But Its Business Still Trails The Market

Benign Growth For Cross Country Healthcare, Inc. (NASDAQ:CCRN) Underpins Stock's 25% Plummet

Feb 22
Benign Growth For Cross Country Healthcare, Inc. (NASDAQ:CCRN) Underpins Stock's 25% Plummet

Calculating The Intrinsic Value Of Cross Country Healthcare, Inc. (NASDAQ:CCRN)

Feb 09
Calculating The Intrinsic Value Of Cross Country Healthcare, Inc. (NASDAQ:CCRN)

Cross Country Healthcare (NASDAQ:CCRN) Is Achieving High Returns On Its Capital

Oct 09
Cross Country Healthcare (NASDAQ:CCRN) Is Achieving High Returns On Its Capital

Should You Investigate Cross Country Healthcare, Inc. (NASDAQ:CCRN) At US$23.23?

Sep 13
Should You Investigate Cross Country Healthcare, Inc. (NASDAQ:CCRN) At US$23.23?

These 4 Measures Indicate That Cross Country Healthcare (NASDAQ:CCRN) Is Using Debt Reasonably Well

Aug 19
These 4 Measures Indicate That Cross Country Healthcare (NASDAQ:CCRN) Is Using Debt Reasonably Well

Returns on Capital Paint A Bright Future For Cross Country Healthcare (NASDAQ:CCRN)

Jun 26
Returns on Capital Paint A Bright Future For Cross Country Healthcare (NASDAQ:CCRN)

At US$27.39, Is It Time To Put Cross Country Healthcare, Inc. (NASDAQ:CCRN) On Your Watch List?

Jun 08
At US$27.39, Is It Time To Put Cross Country Healthcare, Inc. (NASDAQ:CCRN) On Your Watch List?

Is Cross Country Healthcare (NASDAQ:CCRN) Using Too Much Debt?

Apr 28
Is Cross Country Healthcare (NASDAQ:CCRN) Using Too Much Debt?

Returns on Capital Paint A Bright Future For Cross Country Healthcare (NASDAQ:CCRN)

Mar 15
Returns on Capital Paint A Bright Future For Cross Country Healthcare (NASDAQ:CCRN)

Why Cross Country Healthcare, Inc. (NASDAQ:CCRN) Could Be Worth Watching

Mar 02
Why Cross Country Healthcare, Inc. (NASDAQ:CCRN) Could Be Worth Watching

If EPS Growth Is Important To You, Cross Country Healthcare (NASDAQ:CCRN) Presents An Opportunity

Jan 20
If EPS Growth Is Important To You, Cross Country Healthcare (NASDAQ:CCRN) Presents An Opportunity

Cross Country Healthcare (NASDAQ:CCRN) Has A Rock Solid Balance Sheet

Jan 05
Cross Country Healthcare (NASDAQ:CCRN) Has A Rock Solid Balance Sheet

Is Now The Time To Look At Buying Cross Country Healthcare, Inc. (NASDAQ:CCRN)?

Oct 29
Is Now The Time To Look At Buying Cross Country Healthcare, Inc. (NASDAQ:CCRN)?

Investors Shouldn't Overlook Cross Country Healthcare's (NASDAQ:CCRN) Impressive Returns On Capital

Oct 14
Investors Shouldn't Overlook Cross Country Healthcare's (NASDAQ:CCRN) Impressive Returns On Capital

Paring My Cross Country Healthcare Gains

Sep 29

Should You Be Adding Cross Country Healthcare (NASDAQ:CCRN) To Your Watchlist Today?

Sep 26
Should You Be Adding Cross Country Healthcare (NASDAQ:CCRN) To Your Watchlist Today?

Cross Country Healthcare to acquire assets of Mint Medical Physician Staffing, LP and Lotus Medical Staffing LLC

Sep 14

Cross Country Healthcare (NASDAQ:CCRN) Has A Pretty Healthy Balance Sheet

Aug 21
Cross Country Healthcare (NASDAQ:CCRN) Has A Pretty Healthy Balance Sheet

Cross Country Healthcare rises postmarket on $100M stock buyback program

Aug 16

Cross Country Healthcare Q2 Non-GAAP EPS, revenue beats, Q3 guidance provided

Aug 03

Is Cross Country Healthcare, Inc. (NASDAQ:CCRN) Potentially Undervalued?

Jun 16
Is Cross Country Healthcare, Inc. (NASDAQ:CCRN) Potentially Undervalued?

CEO Tazminat Analizi

John Martins'un ücretlendirmesi Cross Country Healthcare'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

US$8m

Mar 31 2024n/an/a

US$46m

Dec 31 2023US$4mUS$869k

US$73m

Sep 30 2023n/an/a

US$102m

Jun 30 2023n/an/a

US$124m

Mar 31 2023n/an/a

US$156m

Dec 31 2022US$3mUS$647k

US$188m

Sep 30 2022n/an/a

US$227m

Jun 30 2022n/an/a

US$216m

Mar 31 2022n/an/a

US$175m

Dec 31 2021US$1mUS$397k

US$132m

Tazminat ve Piyasa: John's total compensation ($USD3.51M) is above average for companies of similar size in the US market ($USD2.42M).

Tazminat ve Kazançlar: John's compensation has been consistent with company performance over the past year.


CEO

John Martins (56 yo)

2.6yrs

Görev süresi

US$3,511,756

Tazminat

Mr. John A. Martins has been the President, Chief Executive Officer and a Director of Cross-Country Healthcare, Inc. since April 02022. He had been the Group President of Delivery at Cross Country Healthca...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Kevin Clark
Co-Founder & Non-Executive Chairman of the Board5.8yrsUS$310.00k1.93%
$ 7.4m
John Martins
President2.6yrsUS$3.51m0.46%
$ 1.8m
William Burns
Executive VP & CFO5.8yrsUS$1.50m0.71%
$ 2.7m
Susan Ball
Chief Administrative Officer20.5yrsUS$1.18m0.52%
$ 2.0m
Marc Krug
Group President of Deliveryno dataUS$953.25k0.10%
$ 395.2k
James Redd
Senior VP & Chief Accounting Officer2yrsVeri yok0.055%
$ 209.0k
Phillip Noe
Chief Information Officer3.5yrsVeri yok0.030%
$ 115.1k
Joshua Vogel
Vice President of Investor Relations2.7yrsVeri yokVeri yok
Karen Varga-Sinka
Director of Corporate Communicationsno dataVeri yokVeri yok
Gerald Purgay
Chief Marketing Officer3.7yrsVeri yokVeri yok
Mark Fortunato
Vice President of Corporate Developmentno dataVeri yokVeri yok
Colin McDonald
Chief Human Resources Officerno dataVeri yok0.072%
$ 274.6k

3.5yrs

Ortalama Görev Süresi

56yo

Ortalama Yaş

Deneyimli Yönetim: CCRN's management team is considered experienced (3.5 years average tenure).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Kevin Clark
Co-Founder & Non-Executive Chairman of the Board5.8yrsUS$310.00k1.93%
$ 7.4m
John Martins
President2.6yrsUS$3.51m0.46%
$ 1.8m
Mark Perlberg
Independent Director9.5yrsUS$240.00k0.28%
$ 1.1m
W. Cash
Lead Independent Director23.1yrsUS$268.75k0.57%
$ 2.2m
Gale Fitzgerald
Independent Director17.5yrsUS$237.25k0.52%
$ 2.0m
Janice Nevin
Independent Director4.5yrsUS$225.00k0.099%
$ 380.8k
Dwayne Allen
Independent Director1.8yrsUS$287.50k0.044%
$ 167.6k
Venkat Bhamidipati
Independent Director2yrsUS$231.25k0.044%
$ 167.1k

5.2yrs

Ortalama Görev Süresi

63yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: CCRN's board of directors are considered experienced (5.2 years average tenure).